Use of soluble forms of the Desmoglein I protein for the purposes of screening for anti-ageing active agents
US9316653B2 · kind B2 · utility
3Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2010 |
| Grant date | Apr 19, 2016 |
| Priority date | — |
| Expiry date | Feb 14, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/795
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of one or more complexed or noncomplexed, soluble peptide form(s) of Desmoglein I, as a marker for evaluating the effectiveness of active agents and/or of treatments, in particular anti-ageing active agents and/or treatments, with regard to an epidermis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.